AI patient-finding is the most transformative capability in a launch. It's also the most oversold, and the difference between the two is everything. The short version: In rare and specialty disease, surfacing miscoded patients isn't incremental. It's the launch. The same pitch aimed at primary care targets a bottleneck that was never the constraint. Either way, a patient the model surfaces still needs a human and a system ready to act. Start with where it's real. In rare and